Exploring the Contribution of Cytochrome P450 Pharmacogenetics to Methadone Enantiomeric Distribution in a Postmortem Setting

BACKGROUND: Interpretation of postmortem methadone concentration is a major challenge in forensic toxicology because therapeutic and fatal concentrations overlap. As methadone is administered as a racemic mixture, and its enantiomers are stereoselectively metabolized by polymorphic cytochrome P450 (CYP) enzymes, inherited differences in CYP activity may influence postmortem enantiomeric distribution. In this study, whether genetically predicted CYP phenotypes are associated with postmortem methadone enantiomeric distribution was investigated. METHODS: Eight methadone-related deaths were prospectively included. Total methadone and R- and S-methadone concentrations were determined in paired femoral blood and vitreous humor samples, using a validated enantioselective liquid chromatography-tandem mass spectrometry method. Multiple CYP enzymes were genotyped using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and metabolizer phenotypes were assigned according to current Clinical Pharmacogenetics Implementation Consortium/Dutch Pharmacogenetics Working Group recommendations. Enantiomeric distribution was assessed using S-methadone/total methadone, R-methadone/total methadone, and S/R-methadone ratios. RESULTS: Enantiomeric ratios were close to racemic equilibrium in femoral blood and vitreous humor, despite considerable interindividual variability in absolute methadone concentrations. There was no consistent association between predicted CYP phenotypes or enantiomeric ratios across biological matrices. Overall, enantiomeric distributions were highly concordant between femoral blood and vitreous humor. CONCLUSIONS: Within the limitations of this exploratory series, there was no consistent association between predicted CYP phenotypes and postmortem methadone enantiomeric distribution. The variability may reflect the contribution of acquired and other nongenetic factors, including phenoconversion. Larger integrative studies that combine pharmacogenetics, toxicological data, and clinical data are warranted.

Authors

Institutions

Publication Details

Journal
Therapeutic Drug Monitoring
Published
2026-11-18
DOI
https://doi.org/10.1097/ftd.0000000000001551
Primary Topic
Forensic Toxicology and Drug Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exploring the Contribution of Cytochrome P450 Pharmacogenetics to Methadone Enantiomeric Distribution in a Postmortem Setting

Marie B Briet, Séverine Ferec, Chadi Abbara, Stéphane Malbranque et al.
1 links
Therapeutic Drug Monitoring
Forensic Toxicology and Drug Analysis
article

Exploring the Contribution of Cytochrome P450 Pharmacogenetics to Methadone Enantiomeric Distribution in a Postmortem Setting

Marie B Briet, Séverine Ferec, Chadi Abbara, Stéphane Malbranque, Guillaume Drevin, Nathalie Jousset, Yassir Tbibi
article en

Abstract

BACKGROUND: Interpretation of postmortem methadone concentration is a major challenge in forensic toxicology because therapeutic and fatal concentrations overlap. As methadone is administered as a racemic mixture, and its enantiomers are stereoselectively metabolized by polymorphic cytochrome P450 (CYP) enzymes, inherited differences in CYP activity may influence postmortem enantiomeric distribution. In this study, whether genetically predicted CYP phenotypes are associated with postmortem methadone enantiomeric distribution was investigated. METHODS: Eight methadone-related deaths were prospectively included. Total methadone and R- and S-methadone concentrations were determined in paired femoral blood and vitreous humor samples, using a validated enantioselective liquid chromatography-tandem mass spectrometry method. Multiple CYP enzymes were genotyped using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and metabolizer phenotypes were assigned according to current Clinical Pharmacogenetics Implementation Consortium/Dutch Pharmacogenetics Working Group recommendations. Enantiomeric distribution was assessed using S-methadone/total methadone, R-methadone/total methadone, and S/R-methadone ratios. RESULTS: Enantiomeric ratios were close to racemic equilibrium in femoral blood and vitreous humor, despite considerable interindividual variability in absolute methadone concentrations. There was no consistent association between predicted CYP phenotypes or enantiomeric ratios across biological matrices. Overall, enantiomeric distributions were highly concordant between femoral blood and vitreous humor. CONCLUSIONS: Within the limitations of this exploratory series, there was no consistent association between predicted CYP phenotypes and postmortem methadone enantiomeric distribution. The variability may reflect the contribution of acquired and other nongenetic factors, including phenoconversion. Larger integrative studies that combine pharmacogenetics, toxicological data, and clinical data are warranted.

Therapeutic Drug Monitoring
Centre National de la Recherche Scientifique (FR), Inserm (FR), Centre Hospitalier Universitaire d'Angers (FR), Mitochondrial and Cardiovascular Physiopathology (FR), Université d'Angers (FR)
Good health and well-being
Forensic Toxicology and Drug Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon